New drugs and perspectives for new anti-tuberculosis regimens

Pulmonology
Simon TiberiG-B Migliori

Abstract

Tuberculosis (TB) is the ninth cause of global death, more than any other infectious disease. With growing drug resistance the epidemic remains and will require significant attention and investment for the elimination of this disease to occur. With susceptible TB treatment not changing over the last four decades and the advent of drug resistance, new drugs and regimens are required. Recently, through greater collaboration and research networks some progress with significant advances has taken place, not withstanding the comparatively low amount of resources invested. Of late the availability of the new drugs bedaquiline, delamanid and repurposed drugs linezolid, clofazimine and carbapenems are being used more frequently in drug-resistant TB regimens. The WHO shorter multidrug-resistant tuberculosis regimen promises to reach more patients and treat them more quickly and more cheaply. With this new enthusiasm and hope we this review gives an update on the new drugs and perspectives for the treatment of drug-susceptible and drug-resistant tuberculosis.

Associated Clinical Trials

Citations

Sep 22, 2018·Journal of Biomolecular Structure & Dynamics·Bala Divya MallavarapuLalitha Guruprasad
Jun 15, 2018·European Respiratory Review : an Official Journal of the European Respiratory Society·Alberto MatteelliGiovanni Battista Migliori
May 1, 2019·Jornal brasileiro de pneumologia : publicaça̋o oficial da Sociedade Brasileira de Pneumologia e Tisilogia·Giovanni Battista MiglioriAdrian Rendon
Jun 28, 2019·Clinical Pharmacology and Therapeutics·Cong HuaiShengying Qin
Mar 5, 2020·Expert Opinion on Drug Delivery·Arbel Artzy-SchnirmanJosué Sznitman
Oct 9, 2019·Journal of Applied Microbiology·R SinghT Prasad
May 7, 2020·Applied Microbiology and Biotechnology·Adetomiwa A AdenijiDu Toit Loots
Dec 14, 2018·Molecular Diversity·Kristina PavićBranka Zorc
Aug 11, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Fabian LentzAndreas Hilgeroth
May 16, 2019·Biochemical Society Transactions·Maria Puiu, Christina Julius
May 18, 2020·Drug Delivery and Translational Research·Bushra NabiJaved Ali
Dec 10, 2020·Future Medicinal Chemistry·Hafij Al MahmudHo-Yeon Song
Dec 19, 2020·Pharmaceuticals·Daria RóżyckaAgnieszka B Olejniczak
Jan 18, 2019·European Journal of Medicinal Chemistry·Vitthal B MakaneHaridas B Rode
Dec 23, 2020·Bioorganic Chemistry·Tejas M DhameliyaAsit K Chakraborti
Nov 23, 2019·European Journal of Medicinal Chemistry·Daniel SzulczykMarta Struga
Feb 2, 2021·European Journal of Medicinal Chemistry·Phelelisiwe S DubeRichard M Beteck
Feb 20, 2021·Frontiers in Microbiology·Alina MiniasJarosław Dziadek
Mar 7, 2021·Biomolecules·Allison M RiceS Bruce King
Mar 7, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Richard M BeteckSetshaba D Khanye
Feb 24, 2021·Antimicrobial Agents and Chemotherapy·Catherine Vilchèze, William R Jacobs
Apr 11, 2021·Clinical Pharmacology and Therapeutics·Charles A Peloquin, Geraint R Davies
May 2, 2021·Chemical Biology & Drug Design·Priscila Cristina Bartolomeu HalickiDaniela Fernandes Ramos
Jun 13, 2021·European Journal of Medicinal Chemistry·Yashodeep ShindeHarun Patel
Jul 20, 2021·Antimicrobial Agents and Chemotherapy·Loes van SchieNico Callewaert
Oct 14, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Negar MaafiLucie Cahlíková

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Related Papers

La Presse médicale
Simon TiberiGiovanni Battista Migliori
© 2022 Meta ULC. All rights reserved